pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

10,142 catalysts · 3,150 8k filing · 2,093 grant · 1,139 approval · 1,000 device adverse event · 865 device 510k · 616 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 43 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-07×clear all
type
  • 8k filing3,150
  • grant2,093
  • approval1,139
  • device adverse event1,000
  • device 510k865
  • device pma616
earnings
584
  • device recall394
  • recall220
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 12, 2026

    50
    ›Jan 14, 2026recall211d agoSignature Formulations, LLC recall (Cls II)

    ORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, ORL Labs, LLC, Scottsdale, Arizona USA — Reason: cGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall211d agoSpecGx, LLC recall (Cls II)SpecGx LLC

    Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 — Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall211d agoSignature Formulations, LLC recall (Cls II)

    ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA — Reason: cGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall211d agoAvKARE recall (Cls II)AvKare LLC

    Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15 — Reason: Out of specification for dissolution. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall211d agoAlembic Pharmaceuticals Limited recall (Cls III)Alembic Pharmaceuticals Inc

    Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30 — Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall211d agoImprimis NJOF, LLC recall (Cls II)OCULAR THERAPEUTIX, INC

    Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01. — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026recall211d agoImprimis NJOF, LLC recall (Cls II)OCULAR THERAPEUTIX, INC

    Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1 — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 14, 2026device 510k211d agoSync Surgical — Cervical Interbody and VBR Fusion System (510k cleared)

    Product code: ODP. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoZiehm-Orthoscan, Inc. — Orthoscan TAU MVP Mini C-Arm System (510k cleared)

    Product code: OXO. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoMeticuly Co., Ltd. — METICULY Patient-specific titanium mesh implant (510k cleared)

    Product code: GXN. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoPhilips Medical Systems Nederland B.V. — dS Base 1.5T; dS Base 3.0T; dS Head 1.5T; dS Head 3.0T; dS HeadNeck 1.5T; dS HeadNeck 3.0T (510k cleared)

    Product code: MOS. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoCardinalhealth — Cardinal Health Nitrile Examination Gloves Extended Cuff (510k cleared)CARDINAL HEALTH INC

    Product code: LZC. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoBrainlab SE — ExacTrac Dynamic (2.0.2); ExacTrac Dynamic Surface (510k cleared)

    Product code: IYE. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoMedtronic Minimed, Inc. — SmartGuard technology; Predictive Low Glucose technology (510k cleared)Medtronic USA Inc

    Product code: QJI. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoLaboratorios Biogalenic S.A. DE C.V. — Laboratorios Biogalenic Sterile Water for Inhalation, USP (510k cleared)

    Product code: BTT. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoMedtronic, Inc. — Concerto Versa™ Detachable Coil (510k cleared)Medtronic plc

    Product code: KRD. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device 510k211d agoEntire Medical , Ltd. — ENTire IRE System (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 14, 2026device pma211d agoTeoxane S.A. — RHA® Redensity dermal filler (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: LMH. Advisory committee: SU. Decision: APPR

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoCardiovascular Systems, Inc. — Diamondback 360™ Coronary Orbital Atherectomy System; Diamondback 360 Precision™ Coronary Orbital Atherectomy System (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: MCX. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoLungpacer Medical USA, Inc. — AeroPace® System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: SDL. Advisory committee: AN. Decision: OK30

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoMedtronic Neuromodulation — InterStim Therapy System, Verify Evaluation System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoAdvanced Medical Solutions Limited — LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: PLJ. Advisory committee: SU. Decision: APPR

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoMedtronic Neuromodulation — InterStim™ Therapy System, Verify™ Evaluation System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoMedtronic Neuromodulation — Altaviva (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QPT. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Jan 14, 2026device pma211d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Jan 14, 2026device recall211d agoEdermy LLC device recall (Cls II)

    PIE PAK Models: P2HC-A, P2HC-S, P2HC — Reason: Lack of 510K clearance — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 14, 2026device recall211d agoEdermy LLC device recall (Cls II)

    PIE Trolley System Model: 2005 — Reason: Lack of 510K clearance — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 14, 2026grant211d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Role of host glutaminolysis in tuberculosis pathogenesis

    GM grant. $196,875. PI: Stephania A Cormier

    full page →nih reporter ↗
    ›Jan 15, 2026approval210d agoOSELTAMIVIR PHOSPHATE — FDA approvalOSELTAMIVIR PHOSPHATE

    Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

    full page →OSELTAMIVIR PHOSPHATE →fda approvals ↗
    ›Jan 15, 2026approval210d agoREZUROCK (BELUMOSUDIL MESYLATE) — FDA approvalbelumosudil mesylate

    Sponsor: KADMON PHARMS LLC. Form: TABLET. Route: ORAL

    full page →belumosudil mesylate →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoOTULFI (USTEKINUMAB-AAUZ) — FDA approvalOTULFI

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →OTULFI →fda approvals ↗
    ›Jan 15, 2026approval210d agoNAPROXEN SODIUM — FDA approvalNAPROXEN SODIUM

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Jan 15, 2026approval210d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 15, 2026approval210d agoFILKRI (FILGRASTIM-LAHA) — FDA approvalfilgrastim biosimilar

    Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: INJECTION

    full page →filgrastim biosimilar →fda approvals ↗
    ›Jan 15, 2026approval210d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 15, 2026approval210d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMacleods Pharmaceuticals Ltd

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoTEPADINA AND SODIUM CHLORIDE (THIOTEPA) — FDA approvalRevalesio Corp

    Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoOXALIPLATIN — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: SHANDONG. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 15, 2026approval210d agoALVAIZ (ELTROMBOPAG CHOLINE) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026device 510k210d agoCuriteva, Inc. — Curiteva Porous PEEK Cervical Interbody Fusion System (510k cleared)

    Product code: ODP. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Jan 15, 2026device 510k210d agoBAAT Medical Products B.V. — SDS Growing Rod (510k cleared)

    Product code: PGM. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 7 of 203
    next →
    $OCUL9.7600+5.63%
    $COLL25.98-4.49%
    $MDT90.68+1.42%
    $OCUL9.7600+5.63%
    $COLL25.98-4.49%
    $BSX51.19+1.45%
    $COLL25.98-4.49%
    $BSX51.19+1.45%
    $CAH240.26+1.30%
    $COLL25.98-4.49%
    $COLL25.98-4.49%
    $COLL25.98-4.49%
    $ABVC
    $COLL25.98-4.49%
    $COLL25.98-4.49%